# Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tofacitinib-alters-stat3-signaling-and-leads-to-endometriosis-lesion-regression/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alexander Kotlyar,Ramanaiah Mamillapalli,Valerie A. Flores,Hugh S. Taylor |
| Citations | 45 |
| DOI | 10.1093/molehr/gaab016 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/molehr/article-pdf/27/4/gaab016/40422355/gaab016.pdf |
| OpenAlex ID | https://openalex.org/W3133957550 |
| PMID | 33693775 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Valerie A. Flores](https://scholariq.org/researchers/valerie-a-flores/)

## Paper primary topic

- [Endometriosis Research and Treatment](https://scholariq.org/topics/endometriosis-research-and-treatment/)

## Paper topics

- [Endometriosis Research and Treatment](https://scholariq.org/topics/endometriosis-research-and-treatment/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.